Gabriel Plotkin Teva Pharmaceutical Industries LTD Transaction History
Melvin Capital Management LP
- $0
- Q3 2023
A detailed history of Gabriel Plotkin (Melvin Capital Management LP) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Melvin Capital Management LP holds 3,420,000 shares of TEVA stock, worth $58.9 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,420,000Holding current value
$58.9 Million% of portfolio
0.24%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TEVA
# of Institutions
640Shares Held
580MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$740 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$671 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$624 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$496 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$468 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.1B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...